AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Cybin Inc. shares rise 7.53% after-hours following CEO Doug Drysdale's resignation and Eric So's appointment as interim CEO.
ByAinvest
Tuesday, Sep 2, 2025 4:20 pm ET1min read
Cybin Inc. rose 7.53% in after-hours trading, following the announcement of senior leadership changes. Doug Drysdale will step down as the Company’s Chief Executive Officer, and Eric So, the Co-Founder and President, has been appointed as Interim Chief Executive Officer. The company is a clinical-stage biopharmaceutical company developing psychedelic-based therapeutics for mental health conditions, with CYB003 moving to Phase III and CYB004 moving to Phase II.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet